- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Therapeutic Mirvetuximab soravtansine ADC from the original Elahere® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
FRɑ |
Antibody-drug conjugate (ADC) |
Elahere® |
5 mg/mL |
– |
2 mg |
tba |
tba |
1.817,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
